box 3(4)
box 3(4)
Triple assessment is a systematic approach for evaluating breast lumps. It consists of:
1. Imaging:
o Mammography (gold standard for >40 years)
o Breast ultrasound (useful in younger women and cystic lesions)
o MRI (for complex cases, high-risk screening)
2. Cytology/Histopathology:
o FNAC (for rapid cytological evaluation)
o Core needle biopsy (for histological diagnosis)
o Excisional biopsy (if other tests are inconclusive)
3. Other Tests:
o Hormone receptor status (ER, PR, HER2 in malignancies)
o Blood tests (tumor markers like CA 15-3 in metastatic cases)
o Genetic testing (BRCA1, BRCA2 in high-risk individuals)
Set 18
a. Classification of benign breast disorders (with examples)
1. Acute:
o Lactational mastitis
o Breast abscess
o Acute bacterial mastitis (Staphylococcus aureus)
2. Subacute:
o Granulomatous mastitis
o Plasma cell mastitis
o Tuberculous mastitis
Set 19
a. Investigations for hepatobiliary system
1. Blood Tests:
o Liver function tests (LFTs)
o Serum bilirubin
o Alkaline phosphatase (ALP) for biliary obstruction
o Tumor markers (AFP for hepatocellular carcinoma)
2. Imaging:
o Ultrasound (first-line for liver pathology)
o CT/MRI (for liver masses, biliary obstruction)
o MRCP/ERCP (for bile duct assessment)
3. Histopathology:
o Liver biopsy (for cirrhosis, malignancy)
b. Indications of splenectomy
c. Complications of splenectomy
1. Immediate:
o Hemorrhage
o Pancreatic injury (fistula)
o Subphrenic abscess
2. Early:
o Thrombocytosis (risk of thrombosis)
o Left lower lobe atelectasis
3. Late:
o Overwhelming Post-Splenectomy Infection (OPSI) – Life-
threatening pneumococcal sepsis.
o Increased susceptibility to encapsulated bacteria (Streptococcus
pneumoniae, Neisseria meningitidis, Haemophilus influenzae).
o Lifelong risk of infections → Requires vaccinations
(Pneumococcal, Meningococcal, H. influenzae B, Influenza).